What is it about?
Patients with severe COPD have been shown to benefit from chronic nocturnal mask ventilation. Currently, it is thought that the initial adjustment to mask ventilation needs a hospitalisation, which is expensive and a burden to the patient. The present study showed that NIV initiation at home is non-inferior to standard in-hospital initiation, is safe, and and reduces costs by over 50%.
Featured Image
Photo by Jessica Rockowitz on Unsplash
Why is it important?
The present study showed that NIV initiation at home is non-inferior to standard in-hospital initiation, is safe, and and reduces costs by over 50%.
Perspectives
With rising numbers of patients referred it is important to control health-care resources. In this way, we are able to optimally support this category of patients.
Marieke Duiverman
University Medical Center Groningen
Read the Original
This page is a summary of: Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial, Thorax, September 2019, BMJ,
DOI: 10.1136/thoraxjnl-2019-213303.
You can read the full text:
Contributors
The following have contributed to this page
